Patients should be encouraged to report any changes in mood or behavior to their healthcare provider and drug safety authority [25]
Long-term success isnt about perfection
In head-to-head comparison during the STEP trials, semaglutide 2.4 mg weekly produced significantly greater weight reduction than liraglutide 3.0 mg daily, approximately 15% versus 7% of body weight over similar timeframes
Exenatide (EXE, half-life 2.5 h), an exogenous GLP-1 analog, has been successfully incorporated into these nanocarriers
Some common medication interactions to be careful of include: Utilizing Rybelsus in conjunction with insulin or insulin secretagogues (such as sulfonylureas) may elevate the likelihood of hypoglycemia, or low blood sugar
However, metformin is a common first-line diabetes medication